Drug Profile
PF 6342674
Alternative Names: PF-06342674; RN-168Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Pfizer
- Class Anti-inflammatories; Antibodies; Antihyperglycaemics
- Mechanism of Action Interleukin 7 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Multiple sclerosis; Type 1 diabetes mellitus